Aethlon Medical, Inc. (NASDAQ:AEMD) has scheduled a conference call for 28th October 2020 at 4:30 PM Eastern Time to announce its 2Q21 financial results.
The conference call will also be webcast live under the investor relations section of the website www.aethlonmedical.com
Earnings Expectation
Aethlon Medical, Inc. is reporting second quarter financial results on Wednesday 28th October 2020, after market close.
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection.
